Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesAmyloid beta-protein stimulates trafficking of cholesterol and caveolin-1 from the plasma membrane to the Golgi complex in mouse primary astrocytesThe toxicity of amyloid β oligomersNeuroprotective Activity of Hypericum perforatum and Its Major ComponentsRedox Imbalance and Viral Infections in Neurodegenerative DiseasesThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentReevaluating Metabolism in Alzheimer's Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle ModelAmyloid beta: multiple mechanisms of toxicity and only some protective effects?Apolipoprotein A-I: insights from redox proteomics for its role in neurodegenerationVitamin Supplementation as an Adjuvant Treatment for Alzheimer's DiseaseInsight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingProteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membraneeIF4A inhibition allows translational regulation of mRNAs encoding proteins involved in Alzheimer's diseaseMetabolomics analysis of Cistus monspeliensis leaf extract on energy metabolism activation in human intestinal cellsRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.Estradiol prevents olfactory dysfunction induced by A-β 25-35 injection in hippocampus.Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's diseaseOxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.Abnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease.Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect.Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.Despite its role in assembly, methionine 35 is not necessary for amyloid beta-protein toxicityBiliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Radix Achyranthis Bidentatae improves learning and memory capabilities in ovariectomized rats.Neuroprotective effect of caffeoylquinic acids from Artemisia princeps Pampanini against oxidative stress-induced toxicity in PC-12 cells.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Phytochemical studies of the phenolic substances in Aster glehni extract and its sedative and anticonvulsant activity.Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid β and other toxins by decreasing mitochondrial respiration and reactive oxygen species production.Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis.Biomarkers of Alzheimer's disease: from central nervous system to periphery?Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.Lack of p53 affects the expression of several brain mitochondrial proteins: insights from proteomics into important pathways regulated by p53.Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.Oxidative stress in Alzheimer disease: synergy between the Butterfield and Markesbery laboratories.Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease
P2860
Q24289511-91D6A5F0-68FD-4219-AA89-1619C39A2302Q24606835-FCA945BF-76D7-4906-88D5-6BBD16EA0B9CQ24631757-829132D1-48BE-48BD-A3C4-037CA575E9F8Q26741405-51DA29F4-1C8A-456A-8082-ABC638E9FF5CQ26750630-B869B9B4-FE2F-4AEF-8455-9F2AC367EB5FQ26823454-6F75CB6F-223F-4729-B1A5-0F108EA4B8FBQ26827320-EDDEDF3E-B826-4702-B764-FED7F44EE1F9Q26864926-B7C0B886-AAF7-4B04-8279-10A3D3794FC0Q27008826-53FE0344-93A1-44E1-AB97-067CB38E19C6Q27026686-65E53F73-B4AD-487D-9396-446363134CF2Q28073374-BC470A8D-0468-42EF-8CA7-7361DEFA6E35Q28076999-5368F8D6-B897-44E0-85A0-1DBAEB5F6DDAQ28477446-45459748-CBFB-4AC9-A9AF-0D3BB914F992Q28749125-A01F76AA-42FF-4C2B-A21E-A30CA3C69DE8Q30395386-23E2AD50-002F-499D-975E-DF75EBD9E97CQ30446460-9CB02EBB-D1E9-4C55-9916-7124249A90F8Q30847085-1815CD30-A68B-4029-9B18-C1855E11DFE6Q31140077-CAAA264A-8B97-460C-8E83-FC053B8AF698Q33494148-0F146E69-69F2-4A44-B527-F49A163BB556Q33506441-4AAECACB-769F-4EC0-9C1E-235C3037E102Q33607471-1A58187C-117A-40C2-A4C5-D9AD123C89BAQ33639885-83D3679A-E58F-450D-84CB-44469F3DB2DAQ33712475-B1F69491-0E75-401D-91C7-DF669608034EQ33854028-4EB7F461-1BD9-49C3-A1CD-39DDA8BBF6B8Q33889224-C15A174A-3112-4A91-AF2B-C3FF1D90975AQ33915362-77A94A13-527D-4225-B5F8-0E5E2D7D6C66Q34012473-F33CD7B3-C9F7-48E4-BBED-051356A33058Q34094516-1547B4DF-9EA0-4C55-8434-ECFADF15579EQ34094560-4AC676BB-6017-472F-9617-9E70444FE446Q34181803-B31F1629-86DD-4FA7-B4F1-3A77788BAD1CQ34193337-937F9144-D165-4EFF-9FBA-78169C1EEA3FQ34220719-CE79F227-5879-4F13-A350-98AC2A1AFA8CQ34297526-3BB6E405-4058-4FA0-B786-21B3714B9D85Q34417983-6798AC81-E444-4D0E-A92F-E43284596546Q34442605-E1B4A847-D438-4600-A750-927F94BA2811Q34495510-9725EEF1-228A-4B1E-BFE1-8AAFBB188B4DQ34499763-E0C8E785-7969-49E0-BB53-6563B29CF5B9Q34556705-B1D56FEE-0BA3-4EBC-B1C8-25D73D066246Q34561160-99BA6F00-A721-47A8-8E51-EB4FF325D7F8Q34700226-25E9995D-56F1-403B-B256-4EBA81F421B2
P2860
Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Roles of amyloid beta-peptide- ...... and mild cognitive impairment.
@ast
Roles of amyloid beta-peptide- ...... and mild cognitive impairment.
@en
type
label
Roles of amyloid beta-peptide- ...... and mild cognitive impairment.
@ast
Roles of amyloid beta-peptide- ...... and mild cognitive impairment.
@en
prefLabel
Roles of amyloid beta-peptide- ...... and mild cognitive impairment.
@ast
Roles of amyloid beta-peptide- ...... and mild cognitive impairment.
@en
P2093
P2860
P1476
Roles of amyloid beta-peptide- ...... and mild cognitive impairment.
@en
P2093
Rukhsana Sultana
Shelley F Newman
Tanea Reed
P2860
P304
P356
10.1016/J.FREERADBIOMED.2007.05.037
P577
2007-06-13T00:00:00Z